If you would invest
10.00 in Generex Biotechnology Corporation on
April 26, 2012 and sell it today you would
earn a total of 0.00 from holding Generex Biotechnology Corporation or generate
0.0% return on investment over
30 days. Generex Biotechnology Corporation is currenly does not generate positive expected returns and assumes 4.61% risk (volatility on return distribution) over the 30 days horizon. In different words, 77% of equities are less volatile than Generex Biotechnology Corporation and 99% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Risk [Daily Volatility] (%)
Given investment horizon of 30 days, Generex Biotechnology Corporation is expected to generate 6.32 times more return on investment than the market. However, the company is 6.32 times more volatile than its market benchmark. It trades about -0.07 of its potential returns per unit of risk. The NYSE is currently generating roughly -0.47 per unit of risk.